mots-c and tirzepatide Frontiers Stacking MOTS-c and Tirzepatide: The

Average body weight reduction: 5 mg weekly: 16.0% reduction (approximately 35 pounds for a 220-pound person) 10 mg weekly: 21.4% reduction (approximately 47 pounds) 15 mg weekly: 22.5% reduction (approximately 50 pounds) Placebo: 2.4% reduction Percentage of participants achieving clinically significant weight loss: 5% or more weight loss: 85% at 5 mg, 89% at 10 mg, 91% at 15 mg 10% or more weight loss: 69% at 5 mg, 78% at 10 mg, 84% at 15 mg 20% or more weight loss: 32% at 5 mg, 49% at 10 mg, 57% at 15 mg Look at those numbers carefully

Nutrients to specifically ask about: Vitamin B12: Reduced food intake, especially in patients previously on metformin (which independently impairs B12 absorption), increases deficiency risk

High-quality peptides for research can be sourced from trusted providers like Pure Tested Peptides

Recent research has also associated these diabetes drugs with decreased bone health since they can reduce bone mineral density and increase bone turnover, potentially increasing fracture risk